NCT07466901 2026-03-12A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical CancerFudan UniversityPhase NA Not yet recruiting30 enrolled